Diabetes increases risk of heart attack death by 50%

Diabetes increases risk of heart attack death by 50%

June 29 2016 A new study has shown the importance of managing type 2 diabetes to help reduce the...

EMA issues warning that Noxafil tablets and oral suspension not interchangeable

EMA issues warning that Noxafil tablets and oral suspension not interchangeable

June 27 2016 The tablet and oral suspension preparations of Noxafil (posaconazole) are not...

GPhC to address issues relating to workplace pressures

GPhC to address issues relating to workplace pressures

June 22 2016 The General Pharmaceutical Council is look at how pharmacy professionalism is being...

RPS supports introduction of disclosure of pharma payments register for health professionals

RPS supports introduction of disclosure of pharma payments register for health professionals

June 20 2016 The Royal Pharmaceutical Society has supported steps being taken to introduce a...

CPPE Community Pharmacy Competence Group re-launches DoC

CPPE Community Pharmacy Competence Group re-launches DoC

June 13 2016 The Declaration of Competence (DoC) framework has been revised and re-launched with...

  • Diabetes increases risk of heart attack death by 50%

    Diabetes increases risk of heart attack death by 50%

    Wednesday, 29 June 2016 11:43
  • EMA issues warning that Noxafil tablets and oral suspension not interchangeable

    EMA issues warning that Noxafil tablets and oral suspension not interchangeable

    Tuesday, 28 June 2016 13:46
  • GPhC to address issues relating to workplace pressures

    GPhC to address issues relating to workplace pressures

    Wednesday, 22 June 2016 14:19
  • RPS supports introduction of disclosure of pharma payments register for health professionals

    RPS supports introduction of disclosure of pharma payments register for health professionals

    Tuesday, 21 June 2016 11:59
  • CPPE Community Pharmacy Competence Group re-launches DoC

    CPPE Community Pharmacy Competence Group re-launches DoC

    Monday, 13 June 2016 11:30

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

GPhC logo RGBApril 25 2016

Of 6,814 routine inspections of pharmacy premises carried out since November 2013, 421 or 6.2% of them did not meet one or more of these three standards.

General Pharmaceutical Council inspections have assessed pharmacies, seeking “evidence from the pharmacy team that standards relating to the privacy, dignity and confidentiality of patients and the public are met,” health minister Lord Prior of Brampton said last week.

“These standards cover the storage of confidential and private information and the physical and governance arrangements for ensuring patients can have private conversations with pharmacy professionals.”

Breaches in meeting the standards were as follows:

  • 274 did not meet standard 1.7 (“Information is managed to protect the privacy, dignity and confidentiality of patients and the public who receive pharmacy services”);
  • 174 did not meet standard 3.2 (“Premises protect the privacy, dignity and confidentiality of patients and the public who receive pharmacy services”); and
  • 73 did not meet standard 5.3 (“Equipment and facilities are used in a way that protects the privacy and dignity of the patients and the public who receive pharmacy services”).

The figures were given in response to a question raised in the House of Lords by Lord Mawhinney, a former health minister in the Major government. He had asked how many pharmacies in the retail sector had been reprimanded or sanctioned by the GPhC, for breaching patient privacy and for breaching patient dignity.

Lord Prior of Brampton had replied that the Department of Health does not hold that information, but the GPhC had supplied it with the figures. He added: “The United Kingdom and Scottish Parliaments recently approved legislation which includes powers to issue an improvement notice or disqualify a pharmacy from the register for a failure to meet the standards. This will improve the GPhC’s ability to protect patients and improve the quality of the pharmacy services they receive.

“In circumstances where the GPhC finds a registered professional’s fitness to practise is called into question it will investigate and can bring proceedings against that individual.”

In a written answer, the Department of Health clarified: “When pharmacy premises have not met one or more of the standards, they are required by the GPhC to complete and implement an improvement action plan.”

Links:

House of Lords Written Questions HL 7521

House of Lords Written Questions HL 7522

Practice News

June 29 2016 The NHS should support clinical pharmacist roles in community pharmacies as well as at GP practices, the New NHS Alliance has proposed.
December 7 2015 Pharmacists in Scotland have been asked to share their views on what politicians need to be made aware of ahead of the Scottish Parliament elections in 2016. The Royal Pharmaceutical Society...